Vivos Inc. files its Q3 2026 report, detailing performance metrics and developments in the surgical and medical instruments industry.
| Name | VIVOS INC |
|---|---|
| CIK | 0001449349 |
| Tickers | RDGL |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 3841 Surgical & Medical Instruments & Apparatus |
| EIN | 800138937 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 509-736-4000 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Vivos Inc. files its Q3 2026 report, detailing performance metrics and developments in the surgical and medical instruments industry.
Vivos Inc. has filed a definitive proxy statement, detailing proposals for shareholder approval, emphasizing corporate governance in the medical instruments sector.
Vivos Inc. raises $1 million through stock offering of 12.5 million shares, enhancing its financial position and supporting operational needs.
Vivos Inc. announces the creation of Series D Convertible Preferred Stock, impacting its capital structure and potentially influencing the medical instruments industry.
501 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 4 | xslF345X06/form4-11202026_071123.xml | 0002131351-26-000016 | 4725 | ||||||
| 2026-11-20 | 4 | xslF345X06/form4-11202026_071106.xml | 0001486806-26-000012 | 5272 | ||||||
| 2026-11-12 | 10-Q | 10-Q | 0001493152-26-051418 | 000-53497 | 261547428 | 34 | 8382944 | 1 | 1 | |
| 2026-11-09 | DEF 14A | DEF 14A | 0001493152-26-050741 | 000-53497 | 261536488 | 34 | 2251640 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 3.02,5.08,8.01,9.01 | 0001493152-26-050077 | 000-53497 | 261525075 | 34 | 359216 | 1 | 1 |
| 2026-10-08 | 4 | xslF345X06/form4-10082026_091051.xml | 0001486807-26-000002 | 8370 | ||||||
| 2026-10-08 | 8-K | 8-K | 1.01,3.02,3.03,5.03,9.01 | 0001493152-26-046354 | 000-53497 | 261450371 | 34 | 277064 | 1 | 1 |
| 2026-10-05 | 8-K | 8-K | 5.03,9.01 | 0001493152-26-045780 | 000-53497 | 261441638 | 34 | 333405 | 1 | 1 |
| 2026-10-01 | 4 | xslF345X06/form4-10012026_091054.xml | 0001486806-26-000010 | 4717 | ||||||
| 2026-09-16 | 4 | xslF345X06/form4-09162026_030932.xml | 0002131351-26-000014 | 5287 | ||||||
| 2026-08-12 | 10-Q | 10-Q | 0001493152-26-037380 | 000-53497 | 261268067 | 34 | 5945416 | 1 | 1 | |
| 2026-08-10 | 4 | xslF345X06/form4-08102026_080837.xml | 0002131351-26-000012 | 4730 | ||||||
| 2026-08-10 | 4 | xslF345X06/form4-08102026_050843.xml | 0001486806-26-000008 | 4732 | ||||||
| 2026-07-22 | 4 | xslF345X06/form4-07222026_070741.xml | 0002131351-26-000010 | 6196 | ||||||
| 2026-07-15 | 4/A | xslF345X06/form4a-07152026_040717.xml | 0002131351-26-000008 | 9628 | ||||||
| 2026-07-15 | 5 | xslF345X06/form5-07152026_040744.xml | 0002131351-26-000006 | 6518 | ||||||
| 2026-07-15 | 4 | xslF345X06/form4-07152026_030727.xml | 0001486806-26-000006 | 4732 | ||||||
| 2026-07-10 | 4 | xslF345X06/form4-07102026_050756.xml | 0002131351-26-000004 | 6194 | ||||||
| 2026-05-14 | 10-Q | 10-Q | 0001493152-26-023146 | 000-53497 | 26979931 | 34 | 5862904 | 1 | 1 | |
| 2026-05-11 | 4 | xslF345X06/form4-05112026_050520.xml | 0001486806-26-000004 | 4731 | ||||||
| 2026-04-28 | 3 | xslF345X06/form3-04282026_080443.xml | 0002131351-26-000002 | 5246 | ||||||
| 2026-03-31 | 10-K | 10-K | 0001493152-26-013701 | 000-53497 | 26815962 | 34 | 6728735 | 1 | 1 | |
| 2026-03-05 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-26-000052 | 024-12713 | 26728358 | 33 | 1817 | |||
| 2026-03-04 | CORRESP | filename1.htm | 0001493152-26-008885 | 10936 | ||||||
| 2026-03-04 | 1-A/A | xsl1-A_X01/primary_doc.xml | 0001493152-26-008813 | 024-12713 | 26719715 | 33 | 2641594 | |||
| 2026-02-24 | UPLOAD | filename1.pdf | 0000000000-26-001868 | 024-12713 | 40896 | |||||
| 2026-02-17 | 1-A | xsl1-A_X01/primary_doc.xml | 0001493152-26-006865 | 024-12713 | 26635787 | 33 | 2565635 | |||
| 2026-01-02 | 4 | xslF345X05/form4-01022026_040118.xml | 0001486806-26-000002 | 4594 | ||||||
| 2025-12-09 | 4 | xslF345X05/form4-12092025_091200.xml | 0001486806-25-000006 | 4595 | ||||||
| 2025-11-20 | 4 | xslF345X05/form4-11212025_121139.xml | 0001486806-25-000004 | 4595 | ||||||
| 2025-11-12 | 10-Q | 10-Q | 0001493152-25-021619 | 000-53497 | 251468288 | 34 | 5827859 | 1 | 1 | |
| 2025-09-24 | 8-K/A | 8-K/A | 1.01,5.02,9.01 | 0001493152-25-014694 | 000-53497 | 251334918 | 34 | 215596 | 1 | 1 |
| 2025-09-22 | 8-K | 8-K | 1.01,5.02,9.01 | 0001493152-25-014345 | 000-53497 | 251327953 | 34 | 22058542 | 1 | 1 |
| 2025-09-18 | 8-K | 8-K | 8.01 | 0001493152-25-014047 | 000-53497 | 251323417 | 34 | 191554 | 1 | 1 |
| 2025-08-14 | 4 | xslF345X05/form4-08142025_060837.xml | 0001415889-25-021810 | 4595 | ||||||
| 2025-08-13 | 10-Q | 10-Q | 0001641172-25-023437 | 000-53497 | 251211090 | 34 | 5882291 | 1 | 1 | |
| 2025-05-09 | 10-Q | form10-q.htm | 0001641172-25-009496 | 000-53497 | 25931605 | 34 | 4599497 | 1 | 1 | |
| 2025-03-24 | 10-K | form10-k.htm | 0001641172-25-000238 | 000-53497 | 25763375 | 34 | 6553854 | 1 | 1 | |
| 2025-02-10 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-25-005623 | 000-53497 | 25605511 | 34 | 240786 | 1 | 1 |
| 2025-02-10 | 8-K | form8-k.htm | 3.02,8.01 | 0001493152-25-005588 | 000-53497 | 25604741 | 34 | 208706 | 1 | 1 |
| 2024-11-18 | 253G2 | form253g2.htm | 0001493152-24-046489 | 024-12456 | 241471176 | 33 | 21665 | |||
| 2024-11-13 | 10-Q | form10-q.htm | 0001493152-24-045032 | 000-53497 | 241452864 | 34 | 5880381 | 1 | 1 | |
| 2024-10-28 | 4 | xslF345X05/form4-10282024_081045.xml | 0001415889-24-025674 | 4601 | ||||||
| 2024-09-30 | 4 | xslF345X05/form4-09302024_040909.xml | 0001415889-24-024085 | 4601 | ||||||
| 2024-08-13 | 4 | xslF345X05/form4-08132024_050824.xml | 0001415889-24-021126 | 4601 | ||||||
| 2024-08-13 | 10-Q | form10-q.htm | 0001493152-24-031540 | 000-53497 | 241200417 | 34 | 4857078 | 1 | 1 | |
| 2024-08-07 | 4 | xslF345X05/form4-08072024_050829.xml | 0001415889-24-020862 | 4601 | ||||||
| 2024-08-02 | 4 | xslF345X05/form4-08022024_120859.xml | 0001415889-24-020572 | 4601 | ||||||
| 2024-07-29 | 4 | xslF345X05/form4-07292024_050707.xml | 0001415889-24-020244 | 4601 | ||||||
| 2024-07-16 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-24-000110 | 024-12456 | 241120873 | 33 | 1825 | |||
| 2024-07-15 | CORRESP | filename1.htm | 0001493152-24-027196 | 11492 | ||||||
| 2024-07-15 | 1-A/A | xsl1-A_X01/primary_doc.xml | 0001493152-24-027192 | 024-12456 | 241115774 | 33 | 1729706 | |||
| 2024-07-12 | UPLOAD | filename1.pdf | 0000000000-24-007952 | 024-12456 | 40955 | |||||
| 2024-07-01 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-24-025735 | 000-53497 | 241088505 | 34 | 226515 | 1 | 1 |
| 2024-06-28 | 1-A | xsl1-A_X01/primary_doc.xml | 0001493152-24-025606 | 024-12456 | 241085652 | 33 | 1619426 | |||
| 2024-06-04 | 4 | xslF345X05/form4-06042024_060646.xml | 0001415889-24-015308 | 4601 | ||||||
| 2024-05-09 | 10-Q | form10-q.htm | 0001493152-24-018525 | 000-53497 | 24932085 | 34 | 4868692 | 1 | 1 | |
| 2024-03-25 | 8-K | form8-k.htm | 1.01,5.02,9.01 | 0001493152-24-011040 | 000-53497 | 24776690 | 34 | 389943 | 1 | 1 |
| 2024-03-18 | 10-K | form10-k.htm | 0001493152-24-010256 | 000-53497 | 24758364 | 34 | 6218025 | 1 | 1 | |
| 2023-12-27 | 8-K | form8-k.htm | 3.02,8.01,9.01 | 0001493152-23-046266 | 000-53497 | 231518408 | 34 | 391226 | 1 | 1 |
| 2023-12-22 | 253G2 | form253g2.htm | 0001493152-23-045782 | 024-11627 | 231506729 | 33 | 17622 | |||
| 2023-12-06 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-23-000378 | 024-11627 | 231470982 | 33 | 1757 | |||
| 2023-12-05 | CORRESP | filename1.htm | 0001493152-23-043686 | 11239 | ||||||
| 2023-11-27 | CORRESP | filename1.htm | 0001493152-23-042810 | 31787 | ||||||
| 2023-11-27 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-23-042809 | 024-11627 | 231441172 | 33 | 2222107 | |||
| 2023-11-14 | 4 | xslF345X05/form4-11142023_041131.xml | 0001415889-23-015057 | 4497 | ||||||
| 2023-11-08 | UPLOAD | filename1.pdf | 0000000000-23-012250 | 44746 | ||||||
| 2023-11-06 | 10-Q | form10-q.htm | 0001493152-23-039464 | 000-53497 | 231379019 | 34 | 5186202 | 1 | 1 | |
| 2023-11-03 | CORRESP | filename1.htm | 0001493152-23-039359 | 46825 | ||||||
| 2023-11-03 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-23-039356 | 024-11627 | 231377210 | 33 | 2117137 | |||
| 2023-10-24 | UPLOAD | filename1.pdf | 0000000000-23-011654 | 45446 | ||||||
| 2023-10-19 | 4 | xslF345X05/form4-10192023_041029.xml | 0001415889-23-014424 | 5055 | ||||||
| 2023-10-11 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-23-036853 | 000-53497 | 231319386 | 34 | 263071 | 1 | 1 |
| 2023-10-10 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-23-036687 | 024-11627 | 231316856 | 33 | 2118666 | |||
| 2023-08-04 | 10-Q | form10-q.htm | 0001493152-23-026796 | 000-53497 | 231143719 | 34 | 4525471 | 1 | 1 | |
| 2023-05-04 | 10-Q | form10-q.htm | 0001493152-23-015400 | 000-53497 | 23887469 | 34 | 4995558 | 1 | 1 | |
| 2023-05-02 | 8-K | form8-k.htm | 3.02,8.01 | 0001493152-23-015144 | 000-53497 | 23877256 | 34 | 206706 | 1 | 1 |
| 2023-03-27 | 4 | xslF345X04/form4-03272023_070322.xml | 0001415889-23-005431 | 4510 | ||||||
| 2023-03-01 | 10-K | form10-k.htm | 0001493152-23-006366 | 000-53497 | 23691924 | 34 | 6011176 | 1 | 1 | |
| 2022-12-15 | 4 | xslF345X03/form4-12162022_121202.xml | 0001415889-22-012603 | 5023 | ||||||
| 2022-11-18 | 4 | xslF345X03/form4-11182022_121128.xml | 0001415889-22-011531 | 5023 | ||||||
| 2022-10-19 | 10-Q | form10-q.htm | 0001493152-22-028874 | 000-53497 | 221318669 | 34 | 5971089 | 1 | 1 | |
| 2022-10-17 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-22-000396 | 024-11627 | 221314817 | 33 | 1757 | |||
| 2022-10-13 | CORRESP | filename1.htm | 0001493152-22-028369 | 10440 | ||||||
| 2022-10-11 | UPLOAD | filename1.pdf | 0000000000-22-011165 | 40679 | ||||||
| 2022-10-03 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-22-027447 | 024-11627 | 221288139 | 33 | 2911623 | |||
| 2022-08-12 | 4 | xslF345X03/form4-08122022_010810.xml | 0001415889-22-008537 | 5016 | ||||||
| 2022-07-25 | 10-Q | form10-q.htm | 0001493152-22-020190 | 000-53497 | 221100835 | 34 | 6004050 | 1 | 1 | |
| 2022-07-11 | 8-K | form8-k.htm | 3.02,8.01,9.01 | 0001493152-22-018978 | 000-53497 | 221075967 | 34 | 448675 | 1 | 1 |
| 2022-07-06 | 253G2 | form253g2.htm | 0001493152-22-018607 | 024-11627 | 221067111 | 33 | 15843 | |||
| 2022-05-10 | 10-Q | form10-q.htm | 0001493152-22-012660 | 000-53497 | 22908844 | 34 | 5375599 | 1 | 1 | |
| 2022-03-29 | 4 | xslF345X03/form4-03292022_080303.xml | 0001415889-22-003417 | 6166 | ||||||
| 2022-03-18 | 4 | xslF345X03/form4-03182022_030355.xml | 0001415889-22-003199 | 6807 | ||||||
| 2022-03-07 | 10-K | form10-k.htm | 0001493152-22-006171 | 000-53497 | 22717820 | 34 | 7518084 | 1 | 1 | |
| 2022-01-27 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-22-002410 | 000-53497 | 22563684 | 34 | 258037 | 1 | 1 |
| 2021-12-08 | 4 | xslF345X03/form4-12082021_041234.xml | 0001415889-21-005797 | 4467 | ||||||
| 2021-10-25 | 10-Q | form10-q.htm | 0001493152-21-026256 | 000-53497 | 211344820 | 34 | 7141858 | 1 | 1 | |
| 2021-10-04 | 4 | xslF345X03/form4-10042021_031024.xml | 0001415889-21-004721 | 8523 | ||||||
| 2021-09-15 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-21-000291 | 024-11627 | 211256870 | 33 | 1753 | |||
| 2021-09-13 | CORRESP | filename1.htm | 0001493152-21-022509 | 10875 | ||||||
| 2021-09-03 | UPLOAD | filename1.pdf | 0000000000-21-010803 | 41056 | ||||||
| 2021-09-01 | 1-A | xsl1-A_X01/primary_doc.xml | 0001493152-21-021769 | 024-11627 | 211229701 | 33 | 2364386 | |||
| 2021-08-10 | 4 | xslF345X03/form4-08102021_020856.xml | 0001415889-21-003838 | 6136 | ||||||
| 2021-08-02 | 10-Q | form10-q.htm | 0001493152-21-018309 | 000-53497 | 211136528 | 34 | 6929969 | 1 | 1 | |
| 2021-06-08 | 4 | xslF345X03/form4-06082021_040638.xml | 0001415889-21-002889 | 10564 | ||||||
| 2021-05-11 | 4 | xslF345X03/ownership.xml | 0001493152-21-010934 | 5303 | ||||||
| 2021-05-10 | 10-Q | form10-q.htm | 0001493152-21-010868 | 000-53497 | 21906396 | 34 | 4601016 | 1 | ||
| 2021-05-07 | 8-K | form8-k.htm | 1.01,5.02,9.01 | 0001493152-21-010775 | 000-53497 | 21903383 | 34 | 195326 | ||
| 2021-05-07 | 4 | xslF345X03/ownership.xml | 0001493152-21-010737 | 8255 | ||||||
| 2021-03-24 | 10-K | form10-k.htm | 0001493152-21-006723 | 000-53497 | 21768723 | 34 | 6092583 | 1 | ||
| 2021-03-02 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-21-000064 | 024-11049 | 21707046 | 33 | 1756 | |||
| 2021-03-02 | CORRESP | filename1.htm | 0001493152-21-005165 | 15544 | ||||||
| 2021-03-01 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-21-005044 | 024-11049 | 21694401 | 33 | 3923345 | |||
| 2021-02-25 | UPLOAD | filename1.pdf | 0000000000-21-002278 | 40651 | ||||||
| 2021-02-17 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-21-004152 | 024-11049 | 21645557 | 33 | 3964610 | |||
| 2020-12-23 | S-8 | forms-8.htm | 0001493152-20-024246 | 333-251665 | 201413409 | 33 | 100645 | |||
| 2020-12-17 | 4 | xslF345X03/ownership.xml | 0001493152-20-023817 | 6618 | ||||||
| 2020-12-10 | 8-K | form8-k.htm | 2.03,3.02,8.01,9.01 | 0001493152-20-023238 | 000-53497 | 201379871 | 34 | 210665 | ||
| 2020-12-02 | 4 | xslF345X03/form4-12022020_021215.xml | 0001415889-20-002765 | 5036 | ||||||
| 2020-11-12 | 4 | xslF345X03/ownership.xml | 0001493152-20-021132 | 4431 | ||||||
| 2020-11-02 | 10-Q | form10-q.htm | 0001493152-20-020309 | 000-53497 | 201280321 | 34 | 6189588 | 1 | ||
| 2020-08-13 | 10-Q/A | form10qa.htm | 0001493152-20-015501 | 000-53497 | 201098936 | 34 | 55850 | |||
| 2020-08-06 | 10-Q | form10-q.htm | 0001493152-20-014762 | 000-53497 | 201078821 | 34 | 6250793 | 1 | ||
| 2020-06-29 | 10-Q | form10-q.htm | 0001493152-20-012175 | 000-53497 | 20999082 | 34 | 6219772 | 1 | ||
| 2020-06-12 | 4 | xslF345X03/ownership.xml | 0001493152-20-011051 | 4431 | ||||||
| 2020-06-03 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-20-000096 | 024-11049 | 20941829 | 33 | 1756 | |||
| 2020-06-02 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-20-010344 | 024-11049 | 20935496 | 33 | 2287931 | |||
| 2020-06-01 | CORRESP | filename1.htm | 0001493152-20-010346 | 9356 | ||||||
| 2020-06-01 | CORRESP | filename1.htm | 0001493152-20-010345 | 29664 | ||||||
| 2020-06-01 | UPLOAD | filename1.pdf | 0000000000-20-004840 | 44321 | ||||||
| 2020-05-21 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-20-009586 | 024-11049 | 20899822 | 33 | 2287269 | |||
| 2020-05-20 | CORRESP | filename1.htm | 0001493152-20-009587 | 29199 | ||||||
| 2020-05-20 | 10-K/A | form10-ka.htm | 0001493152-20-009545 | 000-53497 | 20898761 | 34 | 57361 | |||
| 2020-05-20 | 8-K/A | form-8ka.htm | 8.01 | 0001493152-20-009454 | 000-53497 | 20895604 | 34 | 33666 | ||
| 2020-05-20 | 8-K/A | form-8ka.htm | 8.01 | 0001493152-20-009452 | 000-53497 | 20895584 | 34 | 33626 | ||
| 2020-05-19 | UPLOAD | filename1.pdf | 0000000000-20-004444 | 47218 | ||||||
| 2020-05-18 | 4 | xslF345X03/ownership.xml | 0001493152-20-009276 | 4429 | ||||||
| 2020-05-08 | 8-K | form8-k.htm | 8.01 | 0001493152-20-008061 | 000-53497 | 20860383 | 34 | 30000 | ||
| 2020-04-30 | 1-A POS | xsl1-A_X01/primary_doc.xml | 0001493152-20-007407 | 024-11049 | 20834127 | 33 | 2287017 | |||
| 2020-04-28 | 10-K | form10-k.htm | 0001493152-20-007270 | 000-53497 | 20825461 | 34 | 7507379 | 1 | ||
| 2020-04-20 | 4 | xslF345X03/ownership.xml | 0001493152-20-006710 | 4428 | ||||||
| 2020-03-16 | 8-K | form8-k.htm | 8.01 | 0001493152-20-004097 | 000-53497 | 20718383 | 34 | 28187 | ||
| 2020-02-27 | 4 | xslF345X03/form4-02272020_120211.xml | 0001415889-20-000541 | 9061 | ||||||
| 2020-01-17 | 4/A | xslF345X03/form4a-01172020_040128.xml | 0001415889-20-000140 | 11209 | ||||||
| 2020-01-15 | 4 | xslF345X03/form4-01152020_080132.xml | 0001415889-20-000104 | 10759 | ||||||
| 2019-11-26 | QUALIF | xslQUALIFX01/primary_doc.xml | 9999999994-19-000199 | 024-11049 | 191253106 | 33 | 1753 | |||
| 2019-11-22 | CORRESP | filename1.htm | 0001654954-19-013344 | 8640 | ||||||
| 2019-11-20 | 1-A/A | xsl1-A_X01/primary_doc.xml | 0001493152-19-018130 | 024-11049 | 191234809 | 33 | 2544528 | |||
| 2019-11-14 | 10-Q/A | form10-qa.htm | 0001493152-19-017391 | 000-53497 | 191219422 | 34 | 1280229 | |||
| 2019-11-12 | 10-Q | form10-q.htm | 0001493152-19-016855 | 000-53497 | 191207148 | 34 | 5788539 | 1 | ||
| 2019-10-31 | CORRESP | filename1.htm | 0001415889-19-001237 | 15120 | ||||||
| 2019-10-29 | UPLOAD | filename1.pdf | 0000000000-19-014952 | 51131 | ||||||
| 2019-10-08 | 1-A/A | xsl1-A_X01/primary_doc.xml | 0001493152-19-015257 | 024-11049 | 191143336 | 33 | 3605269 | |||
| 2019-10-08 | CORRESP | filename1.htm | 0001493152-19-015256 | 16940 | ||||||
| 2019-10-02 | 4 | xslF345X03/form4-10022019_061055.xml | 0001415889-19-001134 | 16021 | ||||||
| 2019-09-26 | UPLOAD | filename1.pdf | 0000000000-19-014026 | 49469 | ||||||
| 2019-09-09 | CORRESP | filename1.htm | 0001493152-19-013855 | 42662 | ||||||
| 2019-09-09 | 1-A/A | xsl1-A_X01/primary_doc.xml | 0001493152-19-013853 | 024-11049 | 191082355 | 33 | 3515353 | |||
| 2019-08-23 | UPLOAD | filename1.pdf | 0000000000-19-012835 | 50263 | ||||||
| 2019-08-13 | 10-Q | form10-q.htm | 0001493152-19-012191 | 000-53497 | 191020388 | 34 | 4998934 | 1 | ||
| 2019-07-29 | 1-A | xsl1-A_X01/primary_doc.xml | 0001493152-19-011262 | 024-11049 | 19980032 | 33 | 3806744 | |||
| 2019-07-02 | 8-K | form8-k.htm | 3.03,5.03,8.01,9.01 | 0001493152-19-010114 | 000-53497 | 19936371 | 34 | 97144 | ||
| 2019-06-24 | 10-Q/A | form10-qa.htm | 0001493152-19-009607 | 000-53497 | 19914728 | 34 | 4501820 | 1 | ||
| 2019-05-22 | DEFR14C | DEFR14C | 0001654954-19-006476 | 000-53497 | 19846650 | 34 | 255268 | |||
| 2019-05-16 | DEF 14C | DEF 14C | 0001654954-19-006189 | 000-53497 | 19831677 | 34 | 255672 | |||
| 2019-05-13 | 10-Q | form10-q.htm | 0001493152-19-006916 | 000-53497 | 19818563 | 34 | 4473349 | 1 | ||
| 2019-05-06 | 4 | xslF345X03/form4-05062019_030556.xml | 0001415889-19-000510 | 9588 | ||||||
| 2019-04-30 | 4 | xslF345X03/form4-04302019_050432.xml | 0001415889-19-000490 | 9073 | ||||||
| 2019-04-29 | PRE 14C | PRE 14C | 0001654954-19-004913 | 000-53497 | 19773195 | 34 | 255906 | |||
| 2019-04-02 | 8-K | form8k-04022019_020442.htm | 5.03,9.01 | 0001415889-19-000420 | 000-53497 | 19726040 | 34 | 115971 | ||
| 2019-03-25 | 10-K | form10-k.htm | 0001493152-19-003838 | 000-53497 | 19702082 | 34 | 5689689 | 1 | ||
| 2019-01-31 | 8-K | form8k-01312019_020122.htm | 1.01,3.02,9.01 | 0001415889-19-000109 | 000-53497 | 19556771 | 34 | 16306 | ||
| 2018-12-12 | 3 | xslF345X02/form3-12122018_111249.xml | 0001415889-18-001754 | 9647 | ||||||
| 2018-12-11 | 8-K | form8k-12102018_041257.htm | 5.02 | 0001415889-18-001740 | 000-53497 | 181227549 | 34 | 24978 | ||
| 2018-12-06 | 8-K | form8k-12062018_061201.htm | 5.02 | 0001415889-18-001725 | 000-53497 | 181218603 | 34 | 13701 | ||
| 2018-11-14 | 10-Q | form10-q.htm | 0001493152-18-015945 | 000-53497 | 181182087 | 34 | 2758627 | 1 | ||
| 2018-11-13 | 4 | xslF345X03/form4-11132018_061102.xml | 0001415889-18-001611 | 13277 | ||||||
| 2018-11-09 | 4 | xslF345X03/form4-11092018_111149.xml | 0001415889-18-001602 | 9120 | ||||||
| 2018-10-30 | 8-K | form8-k.htm | 1.01,3.02,5.02,9.01 | 0001493152-18-015013 | 000-53497 | 181148005 | 34 | 136120 | ||
| 2018-10-26 | D | xslFormDX01/primary_doc.xml | 06b | 0001415889-18-001551 | 021-324434 | 181140177 | 33 | 7282 | ||
| 2018-10-17 | 8-K | CURRENT REPORT | 1.01,3.02,5.03,8.01,9.01 | 0001654954-18-011250 | 000-53497 | 181125312 | 34 | 629175 | ||
| 2018-10-16 | UPLOAD | filename1.pdf | 0000000000-18-032472 | 129744 | ||||||
| 2018-10-05 | RW | REQUEST FOR WITHDRAWAL | 0001654954-18-010866 | 333-216588 | 181111106 | NE | 16656 | |||
| 2018-09-25 | 8-K | form8-k.htm | 1.01,9.01 | 0001493152-18-013697 | 000-53497 | 181084612 | 34 | 41930 | ||
| 2018-09-21 | 8-K | form8-k.htm | 1.01 | 0001493152-18-013592 | 000-53497 | 181082067 | 34 | 25957 | ||
| 2018-09-17 | SC 13D/A | Sc13dakwanyee.txt | 0001745338-18-000002 | 005-88318 | 181073754 | 34 | 15305 | |||
| 2018-08-20 | 10-Q | form10-q.htm | 0001493152-18-012269 | 000-53497 | 181027005 | 34 | 2767034 | 1 | ||
| 2018-08-14 | NT 10-Q | formnt-10q.htm | 0001493152-18-011851 | 000-53497 | 181018379 | 34 | 31897 | |||
| 2018-07-18 | SC 13G | SCHEDULE 13G | 0001746805-18-000002 | 005-88318 | 18957364 | 34 | 5858 | |||
| 2018-07-05 | SC 13D | INITIAL 13D FILING - KWAN YEE | 0001745338-18-000001 | 005-88318 | 18940401 | 34 | 17309 | |||
| 2018-05-22 | 10-Q | QUARTERLY REPORT | 0001654954-18-005743 | 000-53497 | 18851783 | 34 | 2104037 | 1 | ||
| 2018-05-15 | NT 10-Q | form12b25-05152018_110556.htm | 0001415889-18-000733 | 000-53497 | 18835455 | 34 | 19371 | |||
| 2018-04-02 | 10-K | form10-k.htm | 0001493152-18-004456 | 000-53497 | 18728774 | 34 | 19876940 | 1 | ||
| 2018-03-09 | UPLOAD | filename1.pdf | 0000000000-18-007502 | 190308 | ||||||
| 2018-02-16 | 5 | xslF345X03/form5-02162018_120218.xml | 0001415889-18-000258 | 105966 | ||||||
| 2018-02-13 | 5 | xslF345X03/form5-02132018_040216.xml | 0001415889-18-000231 | 8698 | ||||||
| 2018-02-13 | 5 | xslF345X03/form5-02132018_040228.xml | 0001415889-18-000230 | 13272 | ||||||
| 2018-02-09 | S-1/A | forms-1a.htm | 0001493152-18-001692 | 333-216588 | 18587321 | 33 | 9875474 | 1 | ||
| 2018-02-08 | CORRESP | filename1.htm | 0001415889-18-000198 | 69219 | ||||||
| 2018-01-25 | 10-K/A | form10-ka.htm | 0001493152-18-000989 | 000-53497 | 18546517 | 34 | 6728640 | 1 | ||
| 2018-01-24 | CORRESP | filename1.htm | 0001415889-18-000122 | 124828 | ||||||
| 2018-01-10 | UPLOAD | filename1.pdf | 0000000000-18-001013 | 134944 | ||||||
| 2018-01-10 | S-8 | forms-8.htm | 0001493152-18-000398 | 333-222494 | 18520987 | 33 | 102613 | |||
| 2018-01-09 | 8-K | form8k-01092018_120107.htm | 5.02 | 0001415889-18-000024 | 000-53497 | 18519035 | 34 | 13679 | ||
| 2018-01-02 | 8-K | form8k-01022018_010106.htm | 5.03,8.01 | 0001415889-18-000004 | 000-53497 | 18502222 | 34 | 54402 | ||
| 2017-12-18 | 8-K | form8k-12182017_021222.htm | 1.01,3.02,9.01 | 0001415889-17-001952 | 000-53497 | 171262272 | 34 | 25115 | ||
| 2017-11-21 | 4 | xslF345X03/form4-11212017_101120.xml | 0001415889-17-001826 | 9025 | ||||||
| 2017-11-13 | 10-Q | form10-q.htm | 0001493152-17-012763 | 000-53497 | 171192826 | 34 | 2988246 | 1 | ||
| 2017-09-15 | 8-K | form8-k.htm | 1.01,5.02 | 0001493152-17-010629 | 000-53497 | 171086547 | 34 | 111854 | ||
| 2017-08-11 | 10-Q | form10-q.htm | 0001493152-17-008943 | 000-53497 | 171024255 | 34 | 4074367 | 1 | ||
| 2017-08-04 | 8-K | form8-k.htm | 5.02,5.07 | 0001493152-17-008551 | 000-53497 | 171009421 | 34 | 52080 | ||
| 2017-08-01 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-17-008360 | 000-53497 | 17997396 | 34 | 1913062 | 1 | 1 |
| 2017-07-10 | DEF 14A | def14a.htm | 0001493152-17-007645 | 000-53497 | 17958432 | 34 | 669331 | |||
| 2017-06-28 | PRE 14A | pre14a.htm | 0001493152-17-007233 | 000-53497 | 17933592 | 34 | 612055 | |||
| 2017-05-17 | 4 | xslF345X03/form4-05172017_060526.xml | 0001415889-17-000793 | 9023 | ||||||
| 2017-05-15 | 10-Q | form10-q.htm | 0001493152-17-005374 | 000-53497 | 17845940 | 34 | 3716895 | 1 | ||
| 2017-04-06 | UPLOAD | filename1.pdf | 0000000000-17-011844 | 190374 | ||||||
| 2017-03-10 | S-1 | FORM S-1 | 0001654954-17-001832 | 333-216588 | 17680073 | 33 | 5652615 | 1 | ||
| 2017-03-09 | 10-K | FORM 10-K | 0001654954-17-001788 | 000-53497 | 17676638 | 34 | 5317140 | 1 | ||
| 2017-01-18 | 4 | xslF345X03/form4-01182017_110109.xml | 0001415889-17-000103 | 10479 | ||||||
| 2017-01-09 | 3 | xslF345X02/form3.xml | 0001493152-17-000267 | 8203 | ||||||
| 2016-12-20 | 8-K | form8k-12202016_091201.htm | 5.02,9.01 | 0001415889-16-007602 | 000-53497 | 162060391 | 34 | 33476 | ||
| 2016-11-21 | 10-Q | form10-q.htm | 0001493152-16-015321 | 000-53497 | 162010271 | 34 | 3956649 | 1 | ||
| 2016-11-15 | NT 10-Q | nt10-q.htm | 0001493152-16-015074 | 000-53497 | 161999166 | 34 | 26851 | |||
| 2016-10-17 | 8-K | form8-k.htm | 5.03,9.01 | 0001493152-16-014063 | 000-53497 | 161937941 | 34 | 42516 | ||
| 2016-09-02 | 8-K | form8-k.htm | 4.01 | 0001493152-16-013053 | 000-53497 | 161866721 | 34 | 19994 | ||
| 2016-08-25 | 8-K | form8-k.htm | 4.01,9.01 | 0001493152-16-012852 | 000-53497 | 161850140 | 34 | 96002 | ||
| 2016-08-18 | 10-Q | form10-q.htm | 0001493152-16-012654 | 000-53497 | 161840789 | 34 | 3697773 | 1 | ||
| 2016-08-15 | NT 10-Q | nt10-q.htm | 0001493152-16-012475 | 000-53497 | 161833569 | 34 | 26921 | |||
| 2016-06-30 | SC 13G | SCHEDULE 13G | 0001078782-16-003056 | 005-88318 | 161743066 | 34 | 49524 | |||
| 2016-06-23 | 4 | xslF345X03/form4.xml | 0001493152-16-011048 | 5377 | ||||||
| 2016-06-10 | 10-Q | form10-q.htm | 0001493152-16-010714 | 000-53497 | 161708451 | 34 | 3478675 | 1 | ||
| 2016-05-26 | 10-K/A | form10-ka.htm | 0001493152-16-010305 | 000-53497 | 161676337 | 34 | 10747046 | 1 | ||
| 2016-05-25 | 10-K | form10-k.htm | 0001493152-16-010291 | 000-53497 | 161675595 | 34 | 10745559 | 1 | ||
| 2016-05-17 | NT 10-Q | nt10-q.htm | 0001493152-16-010039 | 000-53497 | 161658420 | 34 | 26748 | |||
| 2016-05-10 | 4 | xslF345X03/form4.xml | 0001493152-16-009589 | 6880 | ||||||
| 2016-05-03 | 4/A | xslF345X03/form4a.xml | 0001493152-16-009359 | 5565 | ||||||
| 2016-04-18 | 4 | xslF345X03/form4.xml | 0001493152-16-009034 | 5243 | ||||||
| 2016-04-12 | 4 | xslF345X03/form4.xml | 0001493152-16-008813 | 6881 | ||||||
| 2016-04-07 | 4 | xslF345X03/form4.xml | 0001493152-16-008725 | 6564 | ||||||
| 2016-04-07 | 8-K | form8-k.htm | 5.03,5.07,9.01 | 0001493152-16-008703 | 000-53497 | 161558578 | 34 | 160749 | ||
| 2016-03-30 | NT 10-K | ADVANCED MEDICAL ISOTOPE CORP. 12/31/2015 NT 10-K | 0001199835-16-000701 | 000-53497 | 161540417 | 34 | 43737 | |||
| 2016-02-16 | 5 | FORM 5 | 0001140361-16-052638 | 12941 | ||||||
| 2016-02-12 | 5 | FORM 5 | 0001140361-16-052425 | 8674 | ||||||
| 2016-02-12 | 5 | FORM 5 | 0001140361-16-052240 | 19169 | ||||||
| 2016-02-12 | 5 | FORM 5 | 0001140361-16-052153 | 4476 | ||||||
| 2016-02-12 | 4 | FORM 4 | 0001140361-16-052099 | 5604 | ||||||
| 2016-01-21 | 4 | FORM 4 | 0001140361-16-048345 | 5122 | ||||||
| 2016-01-19 | 8-K | ADVANCED MEDICAL ISOTOPE CORPORATION FORM 8-K | 4.01,9.01 | 0001199835-16-000600 | 000-53497 | 161347854 | 34 | 35295 | ||
| 2016-01-15 | SC 13G/A | NONE | 0001140361-16-047890 | 005-88318 | 161345064 | 34 | 112524 | |||
| 2015-12-14 | DEF 14C | admddef14c_nov2015.htm | 0001415889-15-004045 | 000-53497 | 151286382 | 34 | 540913 | |||
| 2015-12-10 | 4 | xslF345X03/form4-12102015_061239.xml | 0001415889-15-004027 | 5556 | ||||||
| 2015-12-10 | 4 | xslF345X03/form4-12102015_061254.xml | 0001415889-15-004025 | 5432 | ||||||
| 2015-11-25 | 10-Q/A | FORM 10-Q | 0001415889-15-003878 | 000-53497 | 151254444 | 34 | 4383108 | 1 | ||
| 2015-11-24 | 10-Q | FORM 10-Q | 0001415889-15-003859 | 000-53497 | 151251458 | 34 | 1150628 | |||
| 2015-11-16 | NT 10-Q | form12b25-11162015_041106.htm | 0001415889-15-003741 | 000-53497 | 151234330 | 34 | 20625 | |||
| 2015-10-30 | PRE 14C | admdpre14c_oct2015.htm | 0001415889-15-003552 | 000-53497 | 151188646 | 34 | 541355 | |||
| 2015-10-08 | 4 | xslF345X03/form4-10082015_021004.xml | 0001415889-15-003330 | 8288 | ||||||
| 2015-09-16 | 8-K | form8k-09152015_050937.htm | 1.01,3.02,9.01 | 0001415889-15-003085 | 000-53497 | 151108755 | 34 | 136350 | ||
| 2015-09-14 | 4 | xslF345X03/form4-09142015_050959.xml | 0001415889-15-003067 | 9936 | ||||||
| 2015-09-11 | 4 | xslF345X03/form4-09112015_060903.xml | 0001415889-15-003032 | 8735 | ||||||
| 2015-09-08 | 4 | xslF345X03/form4-09082015_090904.xml | 0001415889-15-003001 | 5478 | ||||||
| 2015-08-25 | 4 | xslF345X03/form4-08252015_100801.xml | 0001415889-15-002882 | 9804 | ||||||
| 2015-08-19 | 10-Q | 10-Q | 0001415889-15-002806 | 000-53497 | 151064776 | 34 | 4046671 | 1 | ||
| 2015-08-17 | 4 | xslF345X03/form4-08172015_020856.xml | 0001415889-15-002786 | 10516 | ||||||
| 2015-08-14 | NT 10-Q | form12b25-08132015_040814.htm | 0001415889-15-002693 | 000-53497 | 151052161 | 34 | 19800 | |||
| 2015-07-08 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 5.03,9.01 | 0001199835-15-000279 | 000-53497 | 15977518 | 34 | 156369 | ||
| 2015-07-07 | 4 | FORM 4 | 0001140361-15-026990 | 9853 | ||||||
| 2015-07-07 | 4 | FORM 4 | 0001140361-15-026988 | 9723 | ||||||
| 2015-07-01 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 8.01,9.01 | 0001199835-15-000275 | 000-53497 | 15965241 | 34 | 62220 | ||
| 2015-05-27 | 10-Q/A | ADVANCED MEDICAL ISOTOPE CORP. 03/31/2015 10-Q/A, AMENDMENT NO. 1 | 0001199835-15-000231 | 000-53497 | 15892747 | 34 | 3776276 | 1 | ||
| 2015-05-15 | 10-Q | ADVANCED MEDICAL ISOTOPE CORP. 03/31/2015 10-Q | 0001199835-15-000192 | 000-53497 | 15867300 | 34 | 992817 | |||
| 2015-05-04 | 8-K/A | ADVANCED MEDICAL ISOTOPE CORP. 8-K/A, AMENDMENT NO. 1 | 2.04,9.01 | 0001199835-15-000169 | 000-53497 | 15825845 | 34 | 205201 | ||
| 2015-05-01 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 2.04,9.01 | 0001199835-15-000167 | 000-53497 | 15824038 | 34 | 106739 | ||
| 2015-04-30 | 4 | FORM 4 | 0001140361-15-017113 | 10376 | ||||||
| 2015-04-21 | 10-K/A | ADVANCED MEDICAL ISOTOPE CORP. 12/31/2014 10-K/A, AMENDMENT NO. 1 | 0001199835-15-000146 | 000-53497 | 15782641 | 34 | 6338469 | 1 | ||
| 2015-04-20 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 5.02 | 0001199835-15-000140 | 000-53497 | 15779358 | 34 | 28043 | ||
| 2015-04-15 | 10-K | ADVANCED MEDICAL ISOTOPE CORP. 12/31/2014 10-K | 0001199835-15-000132 | 000-53497 | 15772602 | 34 | 2798068 | |||
| 2015-04-09 | 4/A | FORM 4/A | 0001140361-15-014976 | 4607 | ||||||
| 2015-04-09 | 4/A | FORM 4/A | 0001140361-15-014973 | 10652 | ||||||
| 2015-04-09 | 4/A | FORM 4/A | 0001140361-15-014969 | 10691 | ||||||
| 2015-04-09 | 4/A | FORM 4/A | 0001140361-15-014965 | 10654 | ||||||
| 2015-03-31 | NT 10-K | ADVANCED MEDICAL ISOTOPE CORP. NT 10-K | 0001199835-15-000081 | 000-53497 | 15737595 | 34 | 62775 | |||
| 2015-02-26 | 4 | FORM 4 | 0001140361-15-009077 | 4295 | ||||||
| 2015-02-26 | 4 | FORM 4 | 0001140361-15-009067 | 10380 | ||||||
| 2015-02-23 | 5 | FORM 5 | 0001140361-15-008448 | 4425 | ||||||
| 2015-02-23 | 5 | FORM 5 | 0001140361-15-008446 | 12613 | ||||||
| 2015-02-23 | 5 | FORM 5 | 0001140361-15-008443 | 7813 | ||||||
| 2015-02-23 | 5 | FORM 5 | 0001140361-15-008441 | 5772 | ||||||
| 2015-02-23 | 5 | FORM 5 | 0001140361-15-008437 | 41275 | ||||||
| 2015-02-23 | 5 | FORM 5 | 0001140361-15-008434 | 43943 | ||||||
| 2015-02-23 | 4 | FORM 4 | 0001140361-15-008367 | 10379 | ||||||
| 2015-01-16 | 4 | FORM 4 | 0001140361-15-002027 | 10381 | ||||||
| 2015-01-16 | SC 13G/A | NONE | 0001140361-15-001982 | 005-88318 | 15531484 | 34 | 116056 | |||
| 2014-12-22 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 2.03 | 0001199835-14-000639 | 000-53497 | 141302126 | 34 | 23676 | ||
| 2014-12-19 | 4 | FORM 4 | 0001140361-14-045884 | 10384 | ||||||
| 2014-12-19 | 4 | FORM 4 | 0001140361-14-045882 | 6759 | ||||||
| 2014-11-25 | 4 | FORM 4 | 0001140361-14-043408 | 10370 | ||||||
| 2014-11-14 | 4 | FORM 4 | 0001140361-14-042289 | 10372 | ||||||
| 2014-11-14 | 10-Q | ADVANCED MEDICAL ISOTOPE CORPORATION 10K 9-30-2014 | 0001199835-14-000558 | 000-53497 | 141220079 | 34 | 3951263 | 1 | ||
| 2014-10-30 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 5.07,9.01 | 0001199835-14-000525 | 000-53497 | 141183623 | 34 | 156463 | ||
| 2014-10-15 | 4 | FORM 4 | 0001140361-14-038157 | 10372 | ||||||
| 2014-10-02 | DEF 14A | ADVANCED MEDICAL ISOTOPE CORP. DEF 14A | 0001199835-14-000492 | 000-53497 | 141134283 | 34 | 706886 | |||
| 2014-09-25 | PRE 14A | ADVANCED MEDICAL ISOTOPE CORP. PRE 14A | 0001199835-14-000479 | 000-53497 | 141120832 | 34 | 699602 | |||
| 2014-09-19 | SC 13G | NONE | 0001140361-14-036036 | 005-88318 | 141111233 | 34 | 116177 | |||
| 2014-09-17 | 4 | FORM 4 | 0001140361-14-035831 | 10373 | ||||||
| 2014-08-18 | 4 | FORM 4 | 0001140361-14-033287 | 10363 | ||||||
| 2014-08-14 | 10-Q | ADVANCED MEDICAL 10Q 06-30-2014 #16099 | 0001199835-14-000403 | 000-53497 | 141042314 | 34 | 4009072 | 1 | ||
| 2014-07-17 | 4 | FORM 4 | 0001140361-14-028618 | 10361 | ||||||
| 2014-07-09 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 3.02,9.01 | 0001199835-14-000352 | 000-53497 | 14967203 | 34 | 40496 | ||
| 2014-06-17 | 3 | PRIMARY DOCUMENT | 0001117174-14-000003 | 4616 | ||||||
| 2014-06-17 | 4 | FORM 4 | 0001140361-14-025876 | 10363 | ||||||
| 2014-06-12 | 4 | FORM 4 | 0001140361-14-025403 | 4282 | ||||||
| 2014-06-06 | 8-K | advancedmed_8k.htm | 5.07,9.01 | 0001199835-14-000295 | 000-53497 | 14897281 | 34 | 44773 | ||
| 2014-05-19 | 4 | FORM 4 | 0001140361-14-022084 | 10353 | ||||||
| 2014-05-15 | DEF 14A | ADVANCED MEDICAL ISOTOPE CORP. DEF 14A | 0001199835-14-000230 | 000-53497 | 14848769 | 34 | 522065 | |||
| 2014-05-15 | 10-Q | ADVANCED MEDICAL ISOTOPE CORPORATION 10Q 03 31 2014 #15994 | 0001199835-14-000218 | 000-53497 | 14846393 | 34 | 3991126 | 1 | ||
| 2014-05-07 | PRE 14A | ADVANCED MEDICAL ISOTOPE CORPORATION PRE14A 15989 | 0001199835-14-000192 | 000-53497 | 14822127 | 34 | 262890 | |||
| 2014-04-17 | 4 | FORM 4 | 0001140361-14-017057 | 10356 | ||||||
| 2014-03-31 | 10-K | ADVANCED MEDICAL ISOTOPE CORPORATION 10K 12-31-2013 | 0001199835-14-000135 | 000-53497 | 14730707 | 34 | 8745366 | 1 | ||
| 2014-02-05 | 5 | FORM 5 | 0001140361-14-004823 | 27846 | ||||||
| 2014-02-05 | 5 | FORM 5 | 0001140361-14-004821 | 43889 | ||||||
| 2014-02-04 | 5 | FORM 5 | 0001140361-14-004587 | 4409 | ||||||
| 2014-02-04 | 5 | FORM 5 | 0001140361-14-004584 | 13929 | ||||||
| 2014-02-04 | 5 | FORM 5 | 0001140361-14-004582 | 9129 | ||||||
| 2014-02-04 | 5 | FORM 5 | 0001140361-14-004580 | 5756 | ||||||
| 2014-01-17 | 4 | FORM 4 | 0001140361-14-002507 | 10358 | ||||||
| 2014-01-16 | 8-K | AMIC 8K 01-15-2014 | 2.02,9.01 | 0001199835-14-000023 | 000-53497 | 14530691 | 34 | 39541 | ||
| 2013-12-17 | 4 | FORM 4 | 0001140361-13-046508 | 10361 | ||||||
| 2013-11-19 | 10-Q/A | ADVANCED MEDICAL ISOTOPE CORP. 09/30/2013 10-Q/A, AMENDMENT NO. 1 | 0001199835-13-000786 | 000-53497 | 131229890 | 34 | 4351349 | 1 | ||
| 2013-11-15 | 4 | FORM 4 | 0001140361-13-043122 | 10360 | ||||||
| 2013-11-15 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 8.01 | 0001199835-13-000759 | 000-53497 | 131222163 | 34 | 48940 | ||
| 2013-11-14 | 10-Q | ADVANCED MEDICAL ISOTOPE CORP. 09/30/2013 10-Q | 0001199835-13-000751 | 000-53497 | 131220448 | 34 | 1274797 | |||
| 2013-11-01 | 3 | FORM 3 | 0001140361-13-040264 | 6278 | ||||||
| 2013-10-18 | 8-K | ADVANCED MEDICAL ISOTOPE CORPORATION 8K | 5.02,9.01 | 0001199835-13-000682 | 000-53497 | 131157851 | 34 | 188304 | ||
| 2013-10-16 | 4 | FORM 4 | 0001140361-13-038800 | 10360 | ||||||
| 2013-10-16 | 8-K | ADVANCED MEDICAL ISOTOPE CORPORATION FORM 8K | 7.01,9.01 | 0001199835-13-000662 | 000-53497 | 131152888 | 34 | 2370259 | ||
| 2013-09-13 | 4 | FORM 4 | 0001140361-13-035956 | 10365 | ||||||
| 2013-09-09 | 4 | FORM 4 | 0001140361-13-035388 | 4291 | ||||||
| 2013-09-05 | 4/A | FORM 4/A | 0001140361-13-035061 | 10439 | ||||||
| 2013-09-04 | 4/A | FORM 4/A | 0001140361-13-035014 | 10437 | ||||||
| 2013-08-16 | 4 | FORM 4 | 0001140361-13-033408 | 4291 | ||||||
| 2013-08-16 | 4 | FORM 4 | 0001140361-13-033406 | 10361 | ||||||
| 2013-08-14 | 10-Q | ADVANCED MEDICAL ISOTOPE CORP. 06/30/2013 10-Q | 0001199835-13-000503 | 000-53497 | 131038200 | 34 | 5761157 | 1 | ||
| 2013-08-13 | 4 | FORM 4 | 0001140361-13-031951 | 4291 | ||||||
| 2013-08-12 | 4 | FORM 4 | 0001140361-13-031682 | 4292 | ||||||
| 2013-08-01 | 4 | FORM 4 | 0001140361-13-030024 | 10359 | ||||||
| 2013-07-19 | 4 | FORM 4 | 0001140361-13-028475 | 5711 | ||||||
| 2013-07-11 | 4 | FORM 4 | 0001140361-13-027969 | 10360 | ||||||
| 2013-07-02 | 4 | FORM 4 | 0001140361-13-027147 | 4290 | ||||||
| 2013-07-01 | 4 | FORM 4 | 0001140361-13-026905 | 4290 | ||||||
| 2013-06-17 | 4 | FORM 4 | 0001140361-13-025503 | 10362 | ||||||
| 2013-05-21 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 3.02,3.03 | 0001199835-13-000299 | 000-53497 | 13862629 | 34 | 27361 | ||
| 2013-05-15 | 10-Q | ADVANCED MEDICAL ISOTOPE CORP. 03/31/2013 10-Q | 0001199835-13-000250 | 000-53497 | 13843259 | 34 | 3452301 | 1 | ||
| 2013-05-14 | 4 | FORM 4 | 0001140361-13-020498 | 4289 | ||||||
| 2013-05-03 | D | xslFormDX01/primary_doc.xml | 06 | 0001199835-13-000221 | 021-195963 | 13811994 | 33 | 9697 | ||
| 2013-04-24 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 1.01,3.02,9.01 | 0001199835-13-000205 | 000-53497 | 13779888 | 34 | 487964 | ||
| 2013-03-29 | 10-K | ADVANCED MEDICAL ISOTOPE CORP. 10-K | 0001199835-13-000143 | 000-53497 | 13728377 | 34 | 8758947 | 1 | ||
| 2013-03-15 | D | xslFormDX01/primary_doc.xml | 06 | 0001199835-13-000110 | 021-193419 | 13694922 | 33 | 9699 | ||
| 2013-03-15 | 4 | FORM 4 | 0001140361-13-012694 | 4434 | ||||||
| 2013-03-15 | 4 | FORM 4 | 0001140361-13-012676 | 4305 | ||||||
| 2013-03-07 | 8-K | ADVANCED MEDICAL ISOTOPE CORPORATION FORM 8K | 1.01,3.02,9.01 | 0001199835-13-000102 | 000-53497 | 13674158 | 34 | 321333 | ||
| 2013-03-01 | 4 | FORM 4 | 0001140361-13-010157 | 4305 | ||||||
| 2013-02-06 | 5 | FORM 5 | 0001140361-13-005001 | 11811 | ||||||
| 2013-02-06 | 5 | FORM 5 | 0001140361-13-004999 | 43929 | ||||||
| 2013-02-06 | 5 | FORM 5 | 0001140361-13-004970 | 6484 | ||||||
| 2013-02-06 | 5 | FORM 5 | 0001140361-13-004966 | 4431 | ||||||
| 2013-02-06 | 5 | FORM 5 | 0001140361-13-004964 | 3156 | ||||||
| 2013-02-06 | 5 | FORM 5 | 0001140361-13-004958 | 6354 | ||||||
| 2013-01-23 | 4 | FORM 4 | 0001140361-13-002863 | 10360 | ||||||
| 2013-01-22 | 4 | FORM 4 | 0001140361-13-002623 | 10364 | ||||||
| 2013-01-15 | 4 | FORM 4 | 0001140361-13-002191 | 5960 | ||||||
| 2012-12-26 | 4 | FORM 4 | 0001140361-12-052717 | 10365 | ||||||
| 2012-12-10 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2012-12-10 16:00:00 | 9999999995-12-003483 | 333-183705 | 121254802 | 33 | 1683 | ||
| 2012-12-07 | CORRESP | filename1.htm | 0001199835-12-000848 | 10750 | ||||||
| 2012-11-28 | S-1/A | ADVANCED MEDICAL ISOTOPE CORP. S-1/A, AMENDMENT NO. 3 | 0001199835-12-000829 | 333-183705 | 121229213 | 33 | 3273038 | |||
| 2012-11-13 | 10-Q | ADVANCED MEDICAL ISOTOPE CORP. 10-Q | 0001199835-12-000741 | 000-53497 | 121196842 | 34 | 3647163 | 1 | ||
| 2012-11-02 | 4 | FORM 4 | 0001140361-12-045509 | 10358 | ||||||
| 2012-11-02 | 4 | FORM 4 | 0001140361-12-045504 | 4434 | ||||||
| 2012-11-01 | 4 | FORM 4 | 0001140361-12-045169 | 5724 | ||||||
| 2012-10-31 | UPLOAD | filename1.pdf | 0000000000-12-059599 | 207023 | ||||||
| 2012-10-30 | 4 | FORM 4 | 0001140361-12-044983 | 10365 | ||||||
| 2012-10-17 | 4 | FORM 4 | 0001140361-12-044063 | 10365 | ||||||
| 2012-10-16 | S-1/A | ADVANCED MEDICAL ISOTOPE CORP. S-1/A, AMENDMENT NO. 2 | 0001199835-12-000688 | 333-183705 | 121146723 | 33 | 3128951 | |||
| 2012-10-01 | UPLOAD | filename1.pdf | 0000000000-12-053993 | 220363 | ||||||
| 2012-09-14 | 8-K | ADVANCED MEDICAL ISOTOPE CORP. 8-K | 5.02,9.01 | 0001199835-12-000624 | 000-53497 | 121092890 | 34 | 38133 | ||
| 2012-09-12 | 3 | FORM 3 | 0001140361-12-040149 | 3971 | ||||||
| 2012-09-06 | S-1/A | ADVANCED MEDICAL ISOTOPE CORP. S-1/A, AMENDMENT NO. 1 | 0001199835-12-000610 | 333-183705 | 121077632 | 33 | 2839627 | |||
| 2012-09-04 | S-1 | ADVANCED MEDICAL ISOTOPE CORP. S-1 | 0001199835-12-000600 | 333-183705 | 121070610 | 33 | 2807578 | |||
| 2012-08-31 | 4 | FORM 4 | 0001140361-12-039047 | 10363 | ||||||
| 2012-08-20 | 8-K | ADVANCED MEDICAL ISOTOPE CORPORATION FORM 8K | 3.02 | 0001199835-12-000562 | 000-53497 | 121043470 | 34 | 22911 | ||
| 2012-08-17 | 4 | FORM 4 | 0001140361-12-037659 | 4435 | ||||||
| 2012-08-14 | 10-Q | ADVANCED MEDICAL ISOTOPE CORP. 06/30/2012 10-Q | 0001199835-12-000529 | 000-53497 | 121030577 | 34 | 3492663 | 1 | ||
| 2012-08-02 | 8-K | ADVANCED MEDICAL FORM 8K | 1.01,2.03,3.02,8.01 | 0001199835-12-000490 | 000-53497 | 121004155 | 34 | 806328 | ||
| 2012-07-18 | 8-K | ADVANCED MEDICAL FORM 8K | 1.01,2.03,3.02,9.01 | 0001199835-12-000471 | 000-53497 | 12968551 | 34 | 1854509 | ||
| 2012-06-08 | 8-K | ADVANCED MEDICAL FORM 8K 06-04-2012 | 2.03,3.02 | 0001199835-12-000415 | 000-53497 | 12897920 | 34 | 27694 | ||
| 2012-06-01 | 4 | FORM 4 | 0001140361-12-028320 | 10362 | ||||||
| 2012-05-29 | D | xslFormDX01/primary_doc.xml | 06 | 0000893877-12-000065 | 021-178927 | 12874498 | 33 | 10590 | ||
| 2012-05-21 | 4 | FORM 4 | 0001140361-12-026584 | 10362 | ||||||
| 2012-05-14 | 10-Q | ADVANCED MEDICAL FORM 10Q 03-31-2012 | 0001199835-12-000314 | 000-53497 | 12839156 | 34 | 2274988 | 1 |
One latest value per concept from companyfacts (385 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 494.74M | 2026-11-12 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 47.71M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 313,625 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-11-09 | 0001493152-26-050741 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 337,625 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-11-09 | 0001493152-26-050741 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 347,320 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-11-09 | 0001493152-26-050741 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 347,320 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-11-09 | 0001493152-26-050741 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 153 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-11-09 | 0001493152-26-050741 | ||
| invest | InvestmentWarrantsExercisePrice | Investment Warrants, Exercise Price | USD | 0.046 | 2014-05-01 | 2014-05-15 | 2015 | FY | 10-K/A | 2016-05-26 | 0001493152-16-010305 |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 125,438 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | AccountsPayableRelatedPartiesCurrentAndNoncurrent | Accounts Payable, Related Parties | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 | |
| us-gaap | AccountsReceivableNet | Accounts Receivable, after Allowance for Credit Loss | USD | 13,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001493152-22-012660 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 27,825 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 28,846 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-11 | 0001493152-17-008943 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 18,892 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -314 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 83.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | AdditionalPaidInCapitalPreferredStock | Additional Paid in Capital, Preferred Stock | USD | 9.50M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 431,154 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | USD | 59,957 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 1,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 80,059 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 9,995 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 412,980 | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-14 | 0001199835-12-000529 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | -131,090 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 10,800 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities | Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | USD | 983,793 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 0 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q/A | 2019-06-24 | 0001493152-19-009607 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 53,527 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 13,917 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 13,917 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 98.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 43,957 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | Assets | Assets | USD | 2.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | AssetsFairValueDisclosureRecurring | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001654954-17-001788 | |
| us-gaap | CapitalLeaseObligations | Capital Lease Obligations | USD | 2.81M | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 | |
| us-gaap | CapitalLeaseObligationsCurrent | Capital Lease Obligations, Current | USD | 39,481 | 2014-12-31 | 2015 | FY | 10-K/A | 2016-05-26 | 0001493152-16-010305 | |
| us-gaap | CapitalLeaseObligationsNoncurrent | Capital Lease Obligations, Noncurrent | USD | 0 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-23 | 0001199835-12-000130 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueCurrent | Capital Leases, Future Minimum Payments Due, Next Twelve Months | USD | 39,481 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueThereafter | Capital Leases, Future Minimum Payments Due Thereafter | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments | Capital Leases, Future Minimum Payments, Interest Included in Payments | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1 | Capital Leases, Future Minimum Payments, Net Minimum Payments | USD | 39,481 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments | Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments | USD | 39,481 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 | |
| us-gaap | Cash | Cash | USD | 1.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 3.27M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-09 | 0001641172-25-009496 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -8,317 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 1.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 248,825 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.075 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 2.80M | 2026-04-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001493152-26-037380 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 11.24M | 2021-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001493152-22-012660 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 950.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 494.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 494.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | CommonStockShareSubscribedButUnissuedSubscriptionsReceivable | Common Stock, Share Subscribed but Unissued, Subscriptions Receivable | USD | 1,500 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 | |
| us-gaap | CommonStocksIncludingAdditionalPaidInCapital | Common Stocks, Including Additional Paid in Capital | USD | 130,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-09 | 0001493152-24-018525 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 494,738 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | CommonUnitIssued | Common Unit, Issued | shares | 30,644 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -2.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 94,515 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | ConversionOfStockSharesIssued1 | Conversion of Stock, Shares Issued | shares | 10.08M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 |
| us-gaap | ConvertibleDebt | Convertible Debt | USD | 300,000 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-06-29 | 0001493152-20-012175 | |
| us-gaap | ConvertibleDebtCurrent | Convertible Debt, Current | USD | 935,806 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-27 | 0001199835-15-000231 | |
| us-gaap | ConvertibleDebtNoncurrent | Convertible Debt, Noncurrent | USD | 395,102 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 740,000 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 107,418 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 107,418 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 89,644 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 474 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | CostOfServicesDirectMaterials | Cost of Services, Direct Materials (Deprecated 2018-01-31) | USD | 72,820 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 32,110 | 2021-01-01 | 2021-12-31 | 2022 | Q2 | 10-Q | 2022-07-25 | 0001493152-22-020190 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 694,178 | 2020-04-01 | 2020-04-30 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 | Debt Conversion, Converted Instrument, Warrants or Options Issued | shares | 6,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001654954-17-001788 |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | 5,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | DebtCurrent | Debt, Current | USD | 33,086 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001199835-12-000741 | |
| us-gaap | DebtInstrumentAnnualPrincipalPayment | Debt Instrument, Annual Principal Payment | USD | 10,879 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 35,846 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 | |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 1.44M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent | Debt Instrument, Convertible, Carrying Amount of Equity Component | USD | 1.27M | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 0.001 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 | |
| us-gaap | DebtInstrumentConvertibleInterestExpense | Debt Instrument, Convertible, Interest Expense (Deprecated 2013-01-31) | USD | 84,243 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | DebtInstrumentDecreaseForgiveness | Debt Instrument, Decrease, Forgiveness | USD | 129,745 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-02 | 0001493152-21-018309 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 100,000 | 2019-02-20 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | DebtInstrumentFeeAmount | Debt Instrument, Fee Amount | USD | 1.49M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 | |
| us-gaap | DebtInstrumentIncreaseAccruedInterest | Debt Instrument, Increase, Accrued Interest | USD | 185,346 | 2021-12-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | DebtInstrumentIncreaseDecreaseForPeriodNet | Debt Instrument, Increase (Decrease), Net | USD | 809,835 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | DebtInstrumentInterestRateDuringPeriod | Debt Instrument, Interest Rate During Period | pure | 0.1 | 2013-01-01 | 2013-05-01 | 2015 | FY | 10-K/A | 2016-05-26 | 0001493152-16-010305 |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.08 | 2019-02-20 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | DebtInstrumentRepurchaseAmount | Debt Instrument, Repurchase Amount | USD | 228,332 | 2018-04-19 | 2019 | Q2 | 10-Q | 2019-08-13 | 0001493152-19-012191 | |
| us-gaap | DebtInstrumentSinkingFundPayment | Debt Instrument, Sinking Fund Payment | USD | 4.60M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001493152-17-012763 |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 24,545 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumNet | Debt Instrument, Unamortized Discount (Premium), Net | USD | 4,896 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 | |
| us-gaap | DebtInstrumentUnusedBorrowingCapacityAmount | Debt Instrument, Unused Borrowing Capacity, Amount | USD | 419,055 | 2016-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 | |
| us-gaap | DebtIssuanceCosts | Debt Issuance Cost (Deprecated 2016-01-31) | USD | -5,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 |
| us-gaap | DebtorReorganizationItemsGainLossOnAssetSalesNet1 | Debtor Reorganization Items, Gain (Loss) on Asset Sales, Net | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 | Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net | USD | 526,222 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 |
| us-gaap | DeferredFinanceCostsCurrentNet | Debt Issuance Costs, Current, Net | USD | 13,917 | 2014-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 | |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 13,917 | 2014-12-31 | 2015 | FY | 10-K/A | 2016-05-26 | 0001493152-16-010305 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 0 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 | |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 3,400 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001654954-17-001788 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001654954-17-001788 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 7.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 341,200 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 6,400 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 379,800 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 7.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | DepositLiabilitiesAccruedInterest | Deposit Liabilities, Accrued Interest | USD | 114,150 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 | |
| us-gaap | Deposits | Deposits | USD | 370,000 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-14 | 0001199835-12-000529 | |
| us-gaap | DepositsAssetsCurrent | Deposits Assets, Current | USD | 1,000 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001199835-14-000558 | |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 669 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 | |
| us-gaap | Depreciation | Depreciation | USD | 18,518 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1,473 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 |
| us-gaap | DerivativeAssetFairValueGrossLiability | Derivative Asset, Fair Value, Gross Liability | USD | 324,532 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | DerivativeFairValueOfDerivativeLiability | Derivative Liability, Fair Value, Gross Liability | USD | 324,532 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 | |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -186,846 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-04-28 | 0001493152-20-007270 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 30.06M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 | |
| us-gaap | DueFromRelatedParties | Due from Related Parties | USD | 127,533 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | DueToOfficersOrStockholdersCurrent | Due to Officers or Stockholders, Current | USD | 15,000 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-13 | 0001493152-19-012191 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 497,880 | 2020-06-30 | 2020 | Q3 | 10-Q | 2020-11-02 | 0001493152-20-020309 | |
| us-gaap | DueToRelatedPartiesCurrentAndNoncurrent | Due to Related Parties | USD | 127,533 | 2016-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 | |
| us-gaap | DueToRelatedPartiesNoncurrent | Due to Related Parties, Noncurrent | USD | 332,195 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-08-18 | 0001493152-16-012654 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.01 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.01 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.01 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.546 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 66,143 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | EntityWideRevenueMajorCustomerPercentage | Entity-Wide Revenue, Major Customer, Percentage (Deprecated 2013-01-31) | pure | 0.727 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.05 | 2007-07-17 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | ExtinguishmentOfDebtAmount | Extinguishment of Debt, Amount | USD | 5.93M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 77,883 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | FeesAndCommissions | Fees and Commissions (Deprecated 2018-01-31) | USD | 25,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | -112,500 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 25,000 | 2016-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 4,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 10,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-02 | 0001493152-20-020309 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 10,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 4,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001493152-19-016855 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 4,000 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001493152-20-014762 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 4,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001493152-22-012660 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 112,500 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 4,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001493152-22-012660 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | -176,295 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001493152-21-010868 |
| us-gaap | GainLossOnSaleOfOtherAssets | Gain (Loss) on Disposition of Other Assets | USD | 0 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-23 | 0001199835-12-000130 |
| us-gaap | GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome | Gain (Loss) on Sale of Previously Unissued Stock by Subsidiary or Equity Investee, Nonoperating Income | USD | -847,628 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -25,000 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-23 | 0001199835-12-000130 |
| us-gaap | GainLossOnSalesOfAssetsAndAssetImpairmentCharges | Gain (Loss) on Sale of Assets and Asset Impairment Charges | USD | -43,957 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 47,588 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-18 | 0001493152-24-010256 |
| us-gaap | GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost | Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost | USD | 35,217 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 |
| us-gaap | GainsLossesOnRecourseDebt | Gains (Losses) on Recourse Debt | USD | 3,574 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 |
| us-gaap | GainsLossesOnRestructuringOfDebt | Gains (Losses) on Restructuring of Debt | USD | 1.46M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | GainsLossesOnSalesOfAssets | Gain (Loss) on Disposition of Assets for Financial Service Operations | USD | 2,800 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 344,418 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 35,482 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | GrossProfit | Gross Profit | USD | 11,724 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss | Impaired Assets to be Disposed of by Method Other than Sale, Amount of Impairment Loss | USD | 16,661 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -2.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -2.15M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-02 | 0001493152-21-018309 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001654954-17-001788 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-22 | 0001654954-18-005743 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 428,800 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 643,900 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseDepreciation | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount | USD | 113,100 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount | USD | 300 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-04-28 | 0001493152-20-007270 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 6,300 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001641172-25-000238 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 216,100 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -67,100 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 |
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 239,596 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 32,966 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | -6,500 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 5,494 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 |
| us-gaap | IncreaseDecreaseInDeposits | Increase (Decrease) in Deposits | USD | 370,000 | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-14 | 0001199835-12-000529 |
| us-gaap | IncreaseDecreaseInDepositsOutstanding | Increase (Decrease) in Deposits Outstanding | USD | 0 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-23 | 0001199835-12-000130 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | 2.55M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 |
| us-gaap | IncreaseDecreaseInDueToRelatedParties | Increase (Decrease) in Due to Related Parties | USD | 51,576 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | -66,143 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | IncreaseDecreaseInInsuranceSettlementsReceivable | Increase (Decrease) in Insurance Settlements Receivable | USD | 25,000 | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-14 | 0001199835-11-000724 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | -25,399 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -1,260 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 2,011 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayable | Increase (Decrease) in Other Accounts Payable | USD | 141,250 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 9,196 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 4,351 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | 28,793 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-13 | 0001493152-19-012191 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 2.31B | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 11.49B | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 |
| us-gaap | IndefiniteLivedIntangibleAssetsExcludingGoodwill | Indefinite-lived Intangible Assets (Excluding Goodwill) | USD | 35,482 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 | |
| us-gaap | IndefiniteLivedLicenseAgreements | Indefinite-Lived License Agreements | USD | 4,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-10-19 | 0001493152-22-028874 | |
| us-gaap | InducedConversionOfConvertibleDebtExpense | Induced Conversion of Convertible Debt Expense | USD | 78,198 | 2012-07-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001199835-12-000741 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 35,482 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 | |
| us-gaap | InterestExpense | Interest Expense | USD | 25,375 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 1,491 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | InterestExpenseShortTermBorrowings | Interest Expense, Short-term Borrowings | USD | 2,031 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K/A | 2016-05-26 | 0001493152-16-010305 |
| us-gaap | InterestExpenseSubordinatedNotesAndDebentures | Interest Expense, Subordinated Notes and Debentures | USD | 27,685 | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001199835-12-000741 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 49,859 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 9,920 | 2016-01-01 | 2016-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001493152-17-005374 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 50,773 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 100,954 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 619 | 2020-04-30 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 55,997 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 8,475 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 0 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-23 | 0001199835-12-000130 |
| us-gaap | Investments | Investments | USD | 5,000 | 2011-02-28 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 86,419 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 465,739 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.045 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 33,460 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2,788 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 33,460 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 33,460 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | Liabilities | Liabilities | USD | 221,600 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 2.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 155,179 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 3.94M | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 | |
| us-gaap | LiabilitiesFairValueDisclosureRecurring | Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) | USD | 324,532 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 66,421 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 33,086 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001199835-12-000741 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 2,760 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001199835-12-000741 | |
| us-gaap | MarketingAndAdvertisingExpense | Marketing and Advertising Expense | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001493152-22-012660 |
| us-gaap | MarketingExpense | Marketing Expense | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 2.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -193,140 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -1.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -2.50M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001641172-25-000238 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -2.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -797,769 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | NotesIssued1 | Notes Issued | USD | 28,450 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001641172-25-000238 |
| us-gaap | NotesPayable | Notes Payable | USD | 32,279 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 100,000 | 2019-12-31 | 2020 | Q3 | 10-Q | 2020-11-02 | 0001493152-20-020309 | |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 237,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | NotesPayableRelatedPartiesCurrentAndNoncurrent | Notes Payable, Related Parties | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 | |
| us-gaap | NotesReduction | Notes Reduction | USD | 205,283 | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-11 | 0001493152-17-008943 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 2 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 1.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -1.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 26,828 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 96,162 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 29,741 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 66,421 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 90,583 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 36.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 | |
| us-gaap | OtherAssets | Other Assets | USD | 93,583 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -314 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | OtherIncome | Other Income | USD | 3,000 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001493152-20-014762 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 3,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | PaymentsForOperatingActivities | Payments for Operating Activities | USD | 2.30M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001493152-19-016855 |
| us-gaap | PaymentsForOtherDeposits | Payments for Other Deposits | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 438,830 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | PaymentsOfCapitalDistribution | Payments of Capital Distribution | USD | 5,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001654954-17-001788 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 5,000 | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-21 | 0001493152-16-015321 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 5,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | PaymentsOfLoanCosts | Payments of Loan Costs | USD | 101,631 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 0 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-27 | 0001199835-15-000231 |
| us-gaap | PaymentsToAcquireMachineryAndEquipment | Payments to Acquire Machinery and Equipment | USD | 0 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-23 | 0001199835-12-000130 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 193,140 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 20.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 2.77M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 2.77M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 2,770 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 22,152 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | PrepaidExpenseCurrentAndNoncurrent | Prepaid Expense | USD | 11,591 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-14 | 0001199835-14-000558 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 0 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-15 | 0001199835-14-000218 | |
| us-gaap | ProceedsFromContributedCapital | Proceeds from Contributed Capital | USD | 50,000 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 150,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 7.25M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001641172-25-000238 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 1.55M | 2026-03-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001493152-26-023146 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 50,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 19,200 | 2020-11-29 | 2020-12-02 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 650,800 | 2026-04-01 | 2026-04-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001493152-26-037380 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 15,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001493152-21-010868 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 40,949 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | ProceedsFromSaleOfOtherAssets | Proceeds from Sale of Other Assets (Deprecated 2013-01-31) | USD | 0 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-03-23 | 0001199835-12-000130 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 2,800 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 |
| us-gaap | ProceedsFromShortTermDebt | Proceeds from Short-term Debt | USD | -255,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 60,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 1,500 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | ProductionCosts | Production Costs, Period Cost | USD | 2,500 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-04 | 0001493152-23-015400 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 1.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 15,182 | 2017-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 277,433 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | PropertyPlantAndEquipmentOther | Property, Plant and Equipment, Other, Gross | USD | 1,500 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-04 | 0001493152-23-015400 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 20,196 | 2013-01-01 | 2013-06-30 | 2013 | Q2 | 10-Q | 2013-08-14 | 0001199835-13-000503 |
| us-gaap | RelatedPartyTransactionRate | Related Party Transaction, Rate | pure | 0.1 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-13 | 0001493152-17-012763 |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 45,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 228,332 | 2018-04-18 | 2018-04-19 | 2019 | Q1 | 10-Q/A | 2019-06-24 | 0001493152-19-009607 |
| us-gaap | RepaymentsOfDebtAndCapitalLeaseObligations | Repayments of Debt and Lease Obligation | USD | 11,118 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001493152-26-037380 |
| us-gaap | RepaymentsOfLongTermCapitalLeaseObligations | Repayments of Long-term Capital Lease Obligations | USD | 39,481 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-15 | 0001199835-14-000218 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 50,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 40,949 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-09 | 0001654954-17-001788 |
| us-gaap | ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross | USD | 44,268 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-04-21 | 0001199835-15-000146 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 118,907 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | RestrictedStockExpense | Restricted Stock or Unit Expense | USD | 494,935 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001641172-25-023437 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -91.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 101,368 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 17,583 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-22 | 0001654954-18-005743 |
| us-gaap | Revenues | Revenues | USD | 4,995 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001641172-25-000238 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 4,601 | 2017-02-01 | 2017-02-28 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | SalesRevenueEnergyServices | Sales Revenue, Energy Services (Deprecated 2018-01-31) | USD | 265,531 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 24,108 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 |
| us-gaap | SalesRevenueServicesNet | Sales Revenue, Services, Net (Deprecated 2018-01-31) | USD | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-22 | 0001654954-18-005743 |
| us-gaap | SellingAndMarketingExpense | Selling and Marketing Expense | USD | 4,233 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-06-29 | 0001493152-20-012175 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 1.61M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001493152-21-010868 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.66 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-18 | 0001493152-24-010256 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.47 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001493152-21-010868 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.03 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-18 | 0001493152-24-010256 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.006 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001493152-21-010868 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations | shares | 709,375 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-25 | 0001493152-21-026256 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares | 679.10M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K/A | 2016-05-26 | 0001493152-16-010305 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 28,648 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 0.13 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 24.13M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 23.25M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 13.34M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 28,648 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 2.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 0.14 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 540,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 540,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 515,975 | 2023-04-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-04 | 0001493152-23-026796 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 385 | 2019-01-01 | 2019-01-31 | 2020 | FY | 10-K | 2021-03-24 | 0001493152-21-006723 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0.18 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 0.21 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-31 | 0001199835-14-000135 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0.11 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-04-28 | 0001493152-20-007270 |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | USD/shares | 0.04 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-02 | 0001493152-21-018309 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | USD/shares | 0.15 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | USD/shares | 0.04 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-02 | 0001493152-21-018309 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | USD/shares | 0.2 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | SharePrice | Share Price | USD/shares | 0.064 | 2023-12-31 | 2024 | Q1 | 10-Q | 2024-05-09 | 0001493152-24-018525 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 0.1 | 2021-09-15 | 2021 | FY | 10-K | 2022-03-07 | 0001493152-22-006171 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 195,500 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-19 | 0001415889-15-002806 | |
| us-gaap | ShortTermDebtWeightedAverageInterestRate | Short-term Debt, Weighted Average Interest Rate, at Point in Time | pure | 0.1 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-19 | 0001415889-15-002806 | |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 12,592 | 2019-04-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-13 | 0001493152-19-012191 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 2.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 743 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 1.26M | 2021-01-01 | 2021-01-31 | 2021 | Q2 | 10-Q | 2021-08-02 | 0001493152-21-018309 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForCash | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) | shares | 393,333 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 523,750 | 2026-09-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 2.80M | 2026-04-01 | 2026-04-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001493152-26-037380 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardGross | Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares | 100,000 | 2025-04-01 | 2025-04-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001493152-26-037380 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensationGross | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture | shares | 313,120 | 2012-07-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-13 | 0001199835-12-000741 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 2.50M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 226,665 | 2021-01-01 | 2021-03-31 | 2022 | Q3 | 10-Q | 2022-10-19 | 0001493152-22-028874 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments | Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | USD | 109,813 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-25 | 0001415889-15-003878 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 412,011 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0001493152-23-006366 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForCash | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | USD | 410,581 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-29 | 0001199835-13-000143 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 28,038 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 640,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 28,450 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-24 | 0001641172-25-000238 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | -52,094 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-22 | 0001654954-18-005743 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 410,945 | 2012-01-01 | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-08-14 | 0001199835-12-000529 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 250 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-04-02 | 0001493152-18-004456 |
| us-gaap | StockOptionPlanExpense | Stock or Unit Option Plan Expense | USD | 45,400 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-14 | 0001493152-18-015945 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 14.14M | 2016-12-31 | 2016 | FY | 10-K/A | 2018-01-25 | 0001493152-18-000989 | |
| us-gaap | UnrealizedGainLossOnDerivatives | Unrealized Gain (Loss) on Derivatives | USD | 186,846 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-25 | 0001493152-19-003838 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-013701 | |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 20,000 | 2022-07-31 | 2024 | Q1 | 10-Q | 2024-05-09 | 0001493152-24-018525 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 482.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 172.44M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001493152-19-016855 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 482.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001493152-26-051418 |